Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

Sheheryar Kabraji, BMBCh

Dana-Farber Cancer Institute

Presented by 2019 METAbash

Targeting drug-resistant quiescent cancer cells in breast cancer brain metastases

David Kamson, MD, PhD

Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins Hospital

Presented by Jacqueline Vranicar – In memory of Lindsay Block

A Translational Observational Biorepository and Management Study In Patients with Leptomeningeal Metastasis: The BIOLEPT Study

Yibin Kang, PhD

Princeton University

Presented by The Fraternal Order of Eagles

Preventing Regulatory T cell Induction to Enhance Immunity Against Breast Cancer Metastases

YIBIN KANG, PhD

Princeton University

Development of a Humanized Mouse Model of Breast Cancer Liver Metastasis

YIBIN KANG, PhD

Princeton University

Sensitizing Bone Metastasis to Chemotherapy and Radiotherapy by Targeting Jagged1-Mediated Tumor-Stromal Interactions

Bethany Kerr, PhD

Wake Forest School of Medicine

Presented in Honor of Beth Fairchild and Her Service to Metavivor Research and Support

Profiling combinatorial treatment response in early and late bone metastatic breast cancer

Jonathan Kessler, MD

City of Hope / Beckman Research Institute

Presented by Minneapolis Metsquerade in memory of Toniya Lucas and Rachael Masters

Combination of Immune Checkpoint Inhibitor and Hepatic Radioembolization for the Treatment of Liver-Dominant Metastatic Breast Cancer

Tae-Hyung Kim, PhD

University of New Mexico

Harnessing cell mechanotype to regulate the immune evasion of highly metastatic breast cancer cells

BONNIE KING, PhD and CHRISTOPHER CONTAG, PhD

Stanford University

Modeling Therapeutic Strategies for Breast Cancer Metastasis to Bone

Efi Kokkotou, MD, PhD, DSc

Beth Israel Deaconess Medical Center

Presented by the Minneapolis Metsquerade

Repurposing a Melanin-concentrating hormone (MCH) antagonist for the treatment of metastatic breast cancer

Stephen Kron, MD, PhD

The University of Chicago

Mechanisms determining local and systemic anti-tumor immune response after metastasis-directed image-guided radiation combined w

BALAMURUGAN KUPPUSAMY, PhD

This METAvivor funded grant has been accepted and in online as preview in Journal of Clinical Investigation Insight. https://insight.jci.org/in-press-preview

Inflammatory Breast Cancer: Role of the CEBPD-FBXW7 Signaling Pathway